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Objective: To describe the clinical and angiographic characteristics of Takayasu’s arteritis in
Brazilian children and adolescents.
Methods: A retrospective data collection was performed in 71 children and adolescents
followed in 10 Brazilian reference centers in Pediatric Rheumatology. The evaluation was
carried out in three different time points: from onset of symptoms to diagnosis, from the
6th  to 12th month of diagnosis, and in the last visit.
Results: Of 71 selected patients, 51 (71.8%) were girls. The mean age of onset of symptomshild
eenager
mage
and  of time to diagnosis was 9.2 (±4.2) years and 1.2 (±1.4) years, respectively. At the end of
the study, 20 patients were in a state of disease activity, 39 in remission and 5 had evolved to
death. The most common symptoms in baseline assessment, second evaluation, and ﬁnal
evaluation were, respectively: constitutional, musculoskeletal, and neurological symptoms.
 Study linked to the Sector of Pediatric Rheumatology, Department of Pediatrics, Universidade Federal de São Paulo (UNIFESP), São
aulo,  SP, Brazil.
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A decrease in peripheral pulses was the most frequent cardiovascular signal, and an increase
in  erythrocyte sedimentation rate was the most frequent laboratory ﬁnding in all three
evaluation periods. The tuberculin test was positive in 41% of those tested. Stenosis was
the  most frequent angiographic lesion, abdominal artery was the most affected segment,
and  angiographic type IV the most frequent. Most (90%) participants were treated with
glucocorticoids, 85.9% required another immunosuppressive drug, and 29.6% underwent
angioplasty.
Conclusion: This is the largest study on juvenile-onset Takayasu arteritis, and a high number
of  patients under the age of 10 years, with predominance of constitutional symptoms early
in  the disease, was observed.
© 2016 Elsevier Editora Ltda. All rights reserved.
Estudo  multicêntrico  brasileiro  de  71  pacientes  com  arterite  de  Takayasu
juvenil:  características  clínicas  e  angiográﬁcas
Palavras-chave:
Arterite de Takayasu
Crianc¸a
Adolescente
Imagem
r  e  s  u  m  o
Objetivo: Descrever as características clínicas e angiográﬁcas da arterite de Takayasu em
crianc¸as  e adolescentes brasileiros.
Métodos: Foi realizada coleta retrospectiva de dados de 71 crianc¸as e adolescentes acom-
panhados em 10 centros brasileiros de referência em reumatologia pediátrica. A avaliac¸ão
foi  feita em 3 tempos diferentes: início dos sintomas até o diagnóstico, do 6◦ ao 12◦ mês de
diagnóstico e última consulta.
Resultados: Dos 71 pacientes selecionados, 51 (71,8%) eram meninas. As médias de idade
de  início dos sintomas e de tempo até diagnóstico foram 9,2 anos (±4,2) e 1,2 anos (±1,4),
respectivamente. No ﬁnal do estudo, 20 pacientes estavam em atividade de doenc¸a, 39 em
remissão e 5 haviam evoluído ao óbito. Os sintomas mais frequentes nas avaliac¸ão inicial,
segunda avaliac¸ão e avaliac¸ão ﬁnal foram, respectivamente: os constitucionais, os muscu-
loesqueléticos e os neurológicos. A reduc¸ão de pulsos periféricos foi o sinal cardiovascular
mais frequente e a elevac¸ão da velocidade de hemossedimentac¸ão foi o achado laboratorial
mais frequente nos três períodos de avaliac¸ão. O teste tuberculínico foi reagente em 41%
daqueles que o realizaram. A estenose foi a lesão angiográﬁca mais encontrada, a artéria
abdominal foi o segmento mais afetado e tipo angiográﬁco IV o mais frequente. A maioria
(90%) fez terapia com glicocorticoides, 85,9% necessitou de outro imunossupressor e 29,6%
foi  submetido à angioplastia.
Conclusão: Este é o maior estudo de arterite de Takayasu juvenil e nós pudemos observar
elevado número de pacientes com idade inferior a 10 anos e a predominância de sintomas
constitucionais no início da doenc¸a.
© 2016 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Takayasu’s arteritis (TA) is a chronic vasculitis that affects
large- and medium-caliber arteries and is accompanied by
high morbidity, due to an impaired blood supply to organs and
limbs. The disease is rare and affects predominantly young
female adults, being most prevalent in East Asian countries.
This makes TA a poorly characterized disease in the pediatric
population, particularly in Western countries. The descrip-
tions of the disease in the pediatric population, including
infants, has increased in recent decades, often reaching 32%
of patients aged under 20 years.1–5
Clinical signs and symptoms found in patients with
juvenile-onset TA are similar to those found in adults, forinstance, the presence of constitutional, neurological and
musculoskeletal symptoms, high blood pressure, a decrease of
peripheral pulses and presence of vascular murmur. However,
the initial clinical manifestations seem to be more  insidious
and nonspeciﬁc in children.4,6–9 This may contribute to the
greater delay of diagnosis in the pediatric age group, which is
up to four times higher than that for adults.2
The world literature on juvenile-onset AT are scarce, being
derived from speciﬁc populations with small numbers of
patients.3–9 The aim of this study was to describe the clini-
cal and angiographic features of TA at the presentation and
during the course of the disease in children and adolescents,
in order to improve our knowledge about this disease in our
population, thus making easier its diagnosis and preventing
irreparable vascular damage.
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musculoskeletal (42.2%), followed by neurological (35.9%) and
constitutional (32.8%) symptoms; and in the ﬁnal evaluation, a
predominance of neurological symptoms (22.7%) was found,
Table 1 – Clinical and demographic features of patients
with juvenile-onset Takayasu’s arteritis.
Clinical and demographic features n = 71 n (%)
Girls, n (%) 51 (71.8)
Age at onset mean (SD), years 9.2 (±4.2)
Time to diagnosis mean (SD), years 1.2 (±1.4)
Time of progression mean (SD), years 5.4 (±3.7)
Disease progression at the end of study
Activity, n (%) 20 (31.3)a
Remission, n (%) 39 (60.9)a
In use of corticosteroids 11 (28.2)
No steroids 28 (71.8)
Death, n (%) 5 (7.8)ar e v b r a s r e u m a t o l
atients  and  methods
his is a Brazilian multicenter study on clinical, angiographic
nd therapeutic characteristics of patients aged under 19 years
ith a diagnosis of TA. Data collection was carried out between
he 2010 and 2011 through a search of medical records.
enters  involved
ifteen Brazilian tertiary medical centers of reference in Pedi-
tric Rheumatology were invited to participate in this study.
enters with at least three patients with juvenile-onset TA
ho  fulﬁlled the classiﬁcation criteria of the disease10 were
ncluded. The study included 10 Brazilian centers of three dif-
erent geographic regions, including the coordinating center.
articipating  patients
atients with incomplete relevant data were excluded (2
atients). The study included 71 patients followed between
988 and 2011 with a diagnosis of juvenile-onset TA. The
iagnosis was established based on clinical ﬁndings and angi-
graphic images compatible with the disease, with exclusion
f other possible causes; and all patients met  the classiﬁcation
riteria for pediatric Takayasu’s arteritis.10
uestionnaire
 detailed questionnaire containing demographic, clinical,
aboratory, angiographic and therapeutic data was applied.
hese data were collected at three different time points, in
rder to allow a longitudinal follow-up of patients, making
asier the data collection by the head of each participating
enter. The questionnaire was composed of 4 Excel® spread-
heets divided as follows: baseline assessment (referring to
ata from the onset of symptoms to diagnosis establish-
ent); a second evaluation (for data collected between the
th and 12th month of diagnosis); ﬁnal assessment (referring
o data of the last visit and last examination); and treat-
ent (referring to therapy performed during follow-up). This
uestionnaire, along with a Word® document with expla-
ations of how to properly ﬁll out the information and
tandardize the responses, was emailed by the coordinat-
ng center to the doctors responsible for each participating
enter.
Patients were classiﬁed according to disease activity in the
ast six months of the ﬁnal evaluation: disease in activity, in
emission, or death. As there are no validated criteria for deﬁn-
ng disease activity for pediatric patients to date, we deﬁned
disease activity” as the presence of characteristic clinical
ymptoms/signs of the disease and/or laboratory changes
increases in erythrocyte sedimentation rate [VHS] and C-
eactive protein [CRP], with exclusion of other possible causes
or increases in inﬂammatory tests) in the last six months; and
remission” as the absence of clinical signs/symptoms and of
aboratory changes in the last 6 months of follow-up, with
r without pharmacological care. The angiographic examina-
ions were not considered for the evaluation of disease activity,
ue to the large number of participating centers with different 6;5 6(2):145–151 147
imaging modalities (conventional angiography, CTA and MRA)
and also due to the large number of radiologists interpreting
the images.
Angiographic types were deﬁned according to Hata’s angi-
ographic classiﬁcation, developed at the International TA
Conference in Tokyo in 1994, as shown in Fig. 1.11
The study was approved by the Ethics Committee of the
coordinating institution and by the other Committees of the
participating centers.
Results
Of the 71 patients selected for the study, 51 (71.8%) were girls.
At the onset of the disease, 36 patients (50.7%) were children
– younger than 10 years; and 35 (49.3%) were teenagers – aged
10–19 years, according to the deﬁnition of the World Health
Organization. The mean age at onset of symptoms was 9.2
years (±4.2). The means for time to diagnosis and progression
time of the disease were 1.2 (±1.4) years and 5.4 (±3.7) years,
respectively. At the end of the study, 20 patients were with
their disease in activity, 39 in remission (of these, 11 were using
corticosteroids), and 5 died (Table 1). Time till death since the
onset of follow-up was one, two, six and 44 months, respec-
tively (this information was not available for one patient). The
causes of death were heart failure, kidney failure and surgical
complications, and we could not identify the causa mortis of
two patients.
Clinical  ﬁndings
Constitutional symptoms – fever, asthenia and weight loss –
occurred in 77.5% of patients and were the predominant symp-
toms at the baseline assessment, followed by neurological
– headache, stroke, and syncope (70.4%) and musculoskele-
tal – arthritis, arthralgia, and limb pain (64.8%) symptoms;
in the second evaluation, the most frequent symptoms weren, number of patients.
a Values for 64 patients, because in seven we were not able to
assess the presence or absence of disease activity.
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Type I IIa IIb III IV V
grapFig. 1 – Hata’s angio
followed by musculoskeletal – arthritis, arthralgia, and limb
pain (19.7%) and constitutional/gastrointestinal (6.1% each)
symptoms (Table 2).
The most frequent cardiovascular signal was a decrease/
absence of peripheral pulses in the three evaluation periods,
followed by high blood pressure in the ﬁrst evaluation and by a
blood pressure difference in the second and third evaluations
(Table 2).
Table 2 – Clinical and laboratory data of patients with juvenile-
points.
Clinical and laboratory ﬁndings Initial
assessment (71)
n (%)
Constitutional 55 (77.5) 
Neurological 50 (70.4) 
Musculoskeletal 46 (64.8) 
Gastrointestinal 41 (57.7) 
Dyspnea/chest pain 38 (53.5) 
Visual changes 15 (21.1) 
Limb claudication 26 (36.6) 
Decrease/absence of pulses 61 (85.9) 
Hypertension 60 (84.5) 
Heart and arterial bruit 53 (74.6) 
BP difference between limbs > 10 mmHg 48 (67.6) 
Heart failure 13 (18.3) 
Increase of VHS 54/67 (80.6) 
Anemia 35/70 (50.0) 
Leukocytosis 41/69 (59.4) 
Thrombocytosis 30/67 (44.8) 
PPD + 25/58 (43.1) 
ESR, erythrocyte sedimentation rate; PPD, puriﬁed protein derivative.
Constitutional symptoms: fever, asthenia and weight loss; neurological 
arthritis, arthralgia, limb pain; gastrointestinal symptoms: abdominal pai
blurring, blindness, decreased visual acuity, uveitis.
a 6 patients were lost to follow-up after the diagnosis and one of them re
Note: One patient lacked second evaluation data.hic classiﬁcation.11
Laboratory  ﬁndings
Regarding laboratory tests, ESR elevation was the most fre-
quent ﬁnding in all three evaluations, being present in over
80% of patients at baseline assessment, with normalization of
its value in the majority of patients during follow-up. Tuber-
culin skin test was performed in 58 patients, and 25 (43.1%) of
them tested positive (Table 2).
onset Takayasu’s arteritis at the three assessment time
Second
assessment (65)a
n (%)
Final assessment
(66)a n (%)
21/64 (32.8) 4 (6.1)
23/64 (35.9) 15 (22.7)
27/64 (42.2) 13 (19.7)
14/64 (21.8) 4 (6.1)
11/64 (17.2) 3 (4.5)
4/64 (6.2) 3 (4.5)
19/64 (29.7) 10 (15.2)
51/64 (79.7) 44 (66.7)
41/64 (64.0) 29 (43.9)
43/63 (68.3) 37 (56.1)
36/51 (70.6) 40 (60.6)
3/64 (4.7) 0 (0.0)
40/62 (64.5) 20/60 (33.3)
12/64 (18.8) 8/61 (13.1)
21/64 (32.8) 5/61 (8.2)
12/63 (19.0) 2/59 (3.4)
7/26 (26.9) 3/17 (17.6)
symptoms: headache, stroke, syncope; musculoskeletal symptoms:
n, diarrhea, vomiting; visual change: conjunctival hyperemia, visual
turned after 5 years.
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Table 3 – Angiographic classiﬁcation of patients with
juvenile-onset Takayasu’s arteritis, according to Hata’s
classiﬁcation.11
Angiographic classiﬁcation n (%)
Type I 8 (11.9)
Type IIa 4 (6.0)
Type IIb 1 (1.5)
Type III 9 (13.4)
Type IV 27  (40.3)
Type V 18  (26.9)
The frequency of angiographic types described was related to 67
patients, considering that four patients lacked full initial angiogra-
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Table 4 – Pharmacological and interventionist therapy
carried out during follow-up of patients with
juvenile-onset Takayasu’s arteritis.
Treatment Total, n (%)
Corticosteroids 64/71 (90.1)b
Methotrexate 52/71 (73.2)
Cyclophosphamide 36/68 (52.9)b
Azathioprine 7/63 (11.1)b
Mycophenolate 3/66 (4.5) b
Inﬂiximab 4/64 (6.3)b
Antiplatelet 36/68 (52.9)b
Anticoagulant 7/65 (10.8)b
Antihypertensive 58/70 (82.9)b
Latent TB treatmenta 13/67 (19.4)b
TB treatmenta 13/52 (25.0)b
Angioplasty with or without stent 21/71 (29.6)
Bypass 10/71 (14.1)
Nephrectomy 5/71 (7.0)
a One patient was treated for latent tuberculosis (TB) and for
tuberculosis in different times during the monitoring.
b Most percentages were calculated with different denominators,phic data.
During the baseline assessment, 47 patients underwent
onventional angiography, 34 MRA  and 16 TCA. Imaging tests
ere not performed on a considerable number of patients in
he second and third evaluations; in view of that, only the
rst studies were evaluated. According to the study of images
aken at baseline, a change in abdominal aorta was the most
requent ﬁnding, and was present in 67.2% of patients, fol-
owed by renal arteries (55.2%) and by subclavian arteries and
escending thoracic aorta (26.9% each); The most frequent
ype of arterial injury was stenosis (89.6%) followed by obstruc-
ion (28.4%), swelling (17.9%) and aneurysm (14.9%); and the
ost frequent angiographic type was type IV, followed by type
 (Table 3). There was no signiﬁcant difference with respect
o angiographic types among children and adolescents when
ypes I, IIa and IIb were gathered in a group, and types III
nd IV in another group, being subsequently compared among
hemselves and against V group (p = 0.624).
As to drug therapy performed by patients during follow-
p, the majority (90.0%) made use of oral glucocorticoids, or
n the form of pulse therapy. Sixty-one (85.9%) patients used
ther immunosuppressive drugs (methotrexate, cyclophos-
hamide, azathioprine and mycophenolate) and only four
ave used biological therapy (inﬂiximab). Thirty patients
42.3%) used methotrexate and 18 (25.4%) used cyclophos-
hamide as initial immunosuppressive medication. Of the
5 patients with a positive tuberculin skin test, 10 (40.0%)
equired the introduction of triple therapy due to a strong
uspicion of tuberculosis (clinical ﬁndings, chest radiography,
acilloscopy, or biopsy or sputum culture), nine (36.0%) used
soniazid for treatment of latent tuberculosis, and two (8.0%)
ad been treated for latent tuberculosis infection, and were
reated with triple therapy at different follow-up times. Four
16.0%) patients, who  were weak reactors, did not undergo
reatment with triple therapy nor for latent TB. Two patients
ith a negative result for tuberculin test underwent treatment
or tuberculosis (1) and for latent tuberculosis (2), in the face
f their positive epidemiology. Twenty-seven patients (38.0%)
nderwent some kind of interventional therapy, and angio-
lasty was the most performed procedure, in 21 (77.8%) of
hese patients. At the end of this study, the disease evolution
n the group of patients who  underwent surgical procedures
as as follows: 7 (25.9%) were in a state of disease activity, 16
59.3%) were in remission, and 2 (7.4%) had evolved to death.
wo (7.4%) of these patients had no data available (Table 4).according to the questionnaire data of each patient.
Discussion
This study was conducted in a mixed-race country, with large
geographic dimensions and with a large number of patients
with juvenile-onset TA. This allowed us a better knowledge
of the disease in this age group. We  observed a high num-
ber of patients under 10 in our series and a high frequency of
constitutional symptoms at presentation of the disease.
The predominance of females in our study is consistent
with studies in different populations, both in the pediatric
population, where this frequency varies between 58 and 83%,
as in the adult population, that shows an even higher propor-
tion of women.4,5,12–16 The high number of children under 10
years in this study, which included patients up to 18 years
of age at diagnosis, draws attention and differs from Park
et al. series, where 108 children and adults with TA were
evaluated.14 In this study, children up to 10 years at diagno-
sis accounted for 6.5% of all patients, and adolescents aged
between 10 and 20 years accounted for 19%. The mean age at
disease onset was also lower than that found in some studies,
where this mean reached up to 14 years, but higher than the
mean found by Hahn et al. in 31 children of South Africa (8.4
years).5,12,13 We could not justify the variation in age among
the different populations; thus, we hypothesized that genetic
and environmental factors may inﬂuence the earlier onset of
the disease in some regions. The mortality rate of 8% found
in our cohort was similar to that in other studies on pediatric
populations (range: 7–22%).6,12,13 Our patients died in a short
time, which reﬂects the severity of this vasculitis.
Constitutional symptoms were present in almost 80% of
our patients early in the disease and this percentage could be
even higher, if we had included headache in this set of symp-
toms, taking into account that headache can be part of the
inﬂammatory process of the disease, in the absence of cerebral
vessel commitment. As expected, during the patients’ follow-
up these symptoms were less and less observed, reﬂecting a
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lower degree of inﬂammation of the disease after its treat-
ment. Other studies also showed these symptoms in people
with juvenile-onset TA, but their assessment was carried out
separately: fever was present in 4–26% of patients; loss of
weight in 4–47.5%; and fatigue (which was evaluated in a
recent US study), occurred in 38% of patients at the presenta-
tion of the disease.4,5,12,13 The high frequency of constitutional
symptoms in the presentation of TA is a well-known fact,
particularly in pediatric populations; and because of their non-
speciﬁc character, this causes a delay in diagnosis, which in
some patients meant a 4-year setback.
Neurological symptoms were also very prevalent in our
series, with improvement during follow-up, similarly to car-
diovascular signs (lower peripheral pulses and blood pressure),
ﬁndings consistent with the literature.4,6,12,13,17 The decreases
in peripheral pulses and blood pressure, especially the ﬁrst
of these signs, did not show signiﬁcant improvement during
follow-up, as these are secondary manifestations of structural
arterial changes, a thing hardly modiﬁable with therapy.
VHS elevation was the most frequent laboratory ﬁnding in
all three evaluations, reaching 80% of patients at the presen-
tation of the disease, which is consistent with the high rate
of increase in inﬂammatory markers found in other studies
in pediatric patients.5,12,17 Another frequent laboratory ﬁnd-
ing in our patients was a tuberculin skin test positivity, which
was also found in other populations with TA where tubercu-
losis (TB) is endemic, such as Mexico and South Africa.12,18
The high frequency of TB found in our children was much
higher than that reported in healthy Brazilian children by the
Brazilian Institute of Geography and Statistics, thus show-
ing an association between Mycobacterium tuberculosis and
TA.19 It is still unclear the relationship between TB and TA,
but one explanation is that the heat shock protein 65-kDa
found in mycobacteria cross-react with the homologous pro-
tein present in the vascular wall of the host, triggering an
immune response.
Regarding angiographic changes, stenosis was the most
prevalent type of injury, being found in most patients; this
ﬁnding is consistent with studies on adults and children,
where this is the predominant type of injury.4,15 The fre-
quency of aneurysms found in our patients was higher than
the related in studies based on adult populations, ranging
between 5 and 12%.14,15,20,21 The abdominal aorta and renal
arteries were the most affected arterial segments, a ﬁnd-
ing in line with other studies conducted in children.4,13,17,22
The recent study by Szugie et al. found a higher frequency
of involvement of the abdominal aorta and descending tho-
racic aorta; but the renal arteries were analyzed separately,
and possibly their frequency would change if they had been
analyzed together.5 With respect to angiographic type, the
most common was type IV, followed by type V, a ﬁnding a lit-
tle different from that in Indian children, where there was a
higher prevalence of type V, followed by type IV. On the other
hand, our ﬁndings are similar to those in children in South
Africa, where infradiafragmatic commitment (corresponding
to type IV) was the most predominant ﬁnding, followed by
12,13diffuse involvement (corresponding to type V). Angiogra-
phic types presented by adolescents were evaluated separately
from the types presented by children; thus, we  intended to see
if there was more  likeness with the distribution in adults, in 0 1 6;5 6(2):145–151
whom types I and V account for virtually all cases.16 How-
ever, the difference between our adolescents versus adults
remained.
The vast majority of patients needed glucocorticoids and
immunosuppressive drugs during follow-up, as shown in
other studies, and a signiﬁcant portion underwent surgery,
highlighting the chronic and relapsing nature of the disease.23
With this treatment, more  than 60% of patients were in remis-
sion at the end of the study; and this number could possibly
be more  encouraging with a shorter time to diagnosis.
This study enabled us to analyze a signiﬁcant number of
patients with juvenile-onset TA, making this the largest study
in this age group so far. Because of the detailed question-
naire which produced data from three different evaluation
periods, we could describe clinical and laboratory charac-
teristics regarding presentation and evolution of TA in our
population.
The major limitation of this study stemmed from its retro-
spective nature and from the large number of evaluators for
data collection, as well as the use of different radiologists for
interpretation of the angiographic images taken. To minimize
possible discrepancies in assessments from the various cen-
ters involved, a Word® document with explanations of how to
properly ﬁll out the data and standardize the responses was
sent to the doctors responsible for each center.
In our series, that included patients up to 18 years of
age, we  observed a high number of patients under 10 years
and high frequency of constitutional symptoms at TA pre-
sentation. These ﬁndings conﬁrm the importance of the
clinical suspicion with respect to this vasculitis in children
and adolescents, when these populations present long-term
constitutional symptoms of unknown cause, as well as the
importance of checking blood pressure and peripheral pulses
in our routine physical examinations.
Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
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